Accumulation of visceral fat, linked to adipocyte expansion and overgrowth, is the most detrimental aspect of obesity, and a major cause of obesity comorbidities. We develop a cationic nanomedicine based on polyamidoamine dendrimers that specifically targets visceral fat and shrinks adipocytes, inhibiting diet-induced obesity and improving metabolic health in murine models.
- Qianfen Wan
- Baoding Huang
- Li Qiang